Stocks
BioMarin Pharmaceutical (BMRN) ROE US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | -1.50% | 3.08% | 3.39% | 7.54% | 5.73% | 4.33% | ||
| Changes by years, y/y, % | -22pp | +5pp | +0pp | +4pp | -2pp | -22.7% | |||
BioMarin Pharmaceutical. ROE, %
BioMarin Pharmaceutical. ROE, changes, pp
BioMarin Pharmaceutical (BMRN) ROE US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| ROE, % | ? | 9.04% | 10.9% | 8.59% | 5.73% | 4.33% | 4.33% | |
| Changes by years, y/y, % | +5pp | +6pp | +3pp | -2pp | -5pp | |||
| Changes by quarters, q/q, % | +1pp | +2pp | -2pp | -3pp | -1pp | |||
